DentSply Sirona Inc.
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by PR-Newswire.
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ: XRAY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
RADNOR, Pa., Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) ("DENTSPLY").
On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products," and that its "decision was made in consultation with the U.S. Food and Drug Administration (FDA)." On this news, DENTSPLY's stock price fell $1.10 per share, or 4.51%, to close at $23.31 per share on October 25, 2024.
NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ: XRAY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ: XRAY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Der Intraoralscanner der nächsten Generation von Dentsply Sirona eröffnet ein neues Zeitalter in der digitalen Patientenversorgung und ermöglicht das Scannen direkt in die Cloud auf jedem mit dem Internet verbundenen Gerät.
Cloud-nativ, kabellos und sehr vielseitig – das ist Primescan 2. Aufbauend auf der bewährten1 Scantechnologie von Primescan und mit der Möglichkeit, auf jedem internetfähigen Gerät direkt in die Cloud zu scannen, kann Primescan 2 Praxen dabei helfen, ihr Behandlungsangebot zu erweitern, Zeit in den täglichen Arbeitsabläufen zu sparen und ihren Patienten eine exzellente Versorgung bei einem konfortablem Behandlungserlebnis zu bieten.
Dentsply Sirona's next-generation intraoral scanner opens a new era of digital patient care, allowing scanning directly to the cloud on any internet-connected device.
Cloud-native, wireless, and highly versatile — this is Primescan 2. Building upon the proven1 scanning technology of Primescan and with the ability to scan directly to the cloud on any internet-connected device, Primescan 2 can help practices expand their treatment offerings, save time in daily workflows, and deliver enhanced care and comfort to their patients.
